Search
EMA Guidance: Implementing Shortage Prevention Plans (SPP) for Medicines
Ensuring the availability and continuity of medicines across the European Union is an important priority for the European Medicines Regulatory Network. Supply chain disruptions can affect medicine availability, making it important for Marketing Authorisation Holders (MAHs) to identify potential risks and establish appropriate measures to reduce the likelihood of shortages. The European Medicines Agency (EMA) has published the Guidance for industry on implementing Shortage Pre
Sharan Murugan
7 hours ago3 min read